Nicholas Ward's Dividend Growth Portfolio: June 2022 Update

05:46pm, Sunday, 10'th Jul 2022 Seeking Alpha
My passive income was up by 23.32% during June. I made 13 trades during the month; 11 purchases and 2 sales. Click here for my portfolio update for June 2022.

3 Large-Cap Stocks up More Than 20% Year-To-Date

07:37pm, Friday, 08'th Jul 2022 Zacks Investment Research
All three sport strong Zacks Ranks - a significant perk that instills confidence in these companies' share performances moving forward.
All three sport strong Zacks Ranks - a significant perk that instills confidence in these companies' share performances moving forward.

LabCorp's (LH) Base Testing Volume Grows, Costs Rise

03:31pm, Friday, 08'th Jul 2022 Zacks Investment Research
LabCorp's (LH) slew of product launches and collaborations to pursue short- and long-term high-growth opportunities instill optimism.

Here's Why You Should Retain Haemonetics (HAE) Stock For Now

03:14pm, Friday, 08'th Jul 2022 Zacks Investment Research
Investors are optimistic about Haemonetics' (HAE) robust performances across the Hospital and Plasma businesses.

Intercept (ICPT) Reports Positive Data From NASH Study on OCA

03:12pm, Friday, 08'th Jul 2022 Zacks Investment Research
Intercept (ICPT) reports positive top-line results from a new analysis of its ongoing pivotal phase III REGENERATE study of OCA in patients with liver fibrosis due to NASH.

Buy These 4 Blue-Chip Stocks to Strengthen Your Portfolio

11:54am, Friday, 08'th Jul 2022 Zacks Investment Research
We have narrowed our search to four Dow stocks. These are: HD, KO, MRK and JPM.
We have narrowed our search to four Dow stocks. These are: HD, KO, MRK and JPM.

7 Best Biotech Stocks to Buy in July 2022

07:35am, Friday, 08'th Jul 2022
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict. The post 7 Best Biotech Stocks to Buy in July 2022 appeared

Merck (MRK) Stock Sinks As Market Gains: What You Should Know

09:45pm, Thursday, 07'th Jul 2022 Zacks Investment Research
Merck (MRK) closed at $93.01 in the latest trading session, marking a -0.13% move from the prior day.

Merck (MRK) in Advanced Talks to Buy Seagen (SGEN) Per WSJ

03:58pm, Thursday, 07'th Jul 2022 Zacks Investment Research
Reportedly, Merck (MRK) could offer at least $40 billion to buy Seagen (SGEN). If both companies go through with the deal, it will expand Merck's oncology portfolio/pipeline.

Bruker (BRKR) Debuts NMR Test for Research on Long COVID Risks

03:34pm, Thursday, 07'th Jul 2022 Zacks Investment Research
Bruker's (BRKR) PhenoRisk PACS RuO will facilitate clinical research to combat the risks of Long COVID syndrome.
Jared Holz, Oppenheimer healthcare equity strategist, joins 'Power Lunch' to discuss the possibility of M&A in the healthcare sector, if investors remain focused on the oncology side of healthcare bus

Intercept (ICPT) Ocaliva Drives Growth, Pipeline Setbacks Hurt

03:23pm, Thursday, 07'th Jul 2022 Zacks Investment Research
Intercept (ICPT) currently has only one marketed product in its portfolio, Ocaliva, for treating PBC. The company continues to evaluate the potential of OCA in treating progressive liver diseases.

Merck's Oncology Business Will Help It Crush the Bear Market

02:45pm, Thursday, 07'th Jul 2022 The Motley Fool
The drugmaker is defying the stock market sell-off right now.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE